Best Practices Fo Early Diagnosis of Cerebral Palsy
NCT06537622
Brain Damage, Chronic, Brain Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT Number: NCT07141654
This study aims to evaluate the validity of family-led recordings for General Movements Assessment (GMA) compared to provider-led recordings in neonates born <29 weeks.
Trial opening soon.
Get NotifiedUp to 29 week
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollment up to the 18 months corrected age
evaluate the validity of family-led recordings for General Movement Assessment (GMA) compared to provider-led recordings in neonates born <29 weeks using the Prechtl Qualitative General Movements Assessment
Time frame: From enrollment up to 18 months corrected age
to measure the prognostic value of the GMA in predicting Cerebral Palsy(CP) at 18 months corrected age. Information on patient characteristics and outcomes will be collected from the local Canadian Neonatal Network (CNN) and Canadian Neonatal Follow Up Network (CNFUN) databases for all infants meeting inclusion criteria. Additional data around GMA and neurodevelopment not included in the CNN/CNFUN databases will be collected through electronic medical chart review of all infants meeting inclusion criteria.
Time frame: From enrollment up to 18 months corrected age
to assess the age at referral for community rehabilitation services for infants with GMA early signs of CP using patient electronic charts
Time frame: From enrollment up to 18 months corrected age
to assess the parental satisfaction with the GMA administration process and the training materials provided using a feedback questionnaire
McGill University Health Centre/Research Institute of the McGill University Health Centre
Other
Empowering Families in Early Detection: Implementing Family-Led Recording for Early Diagnosis of Cerebral Palsy in Preterm Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06537622
Brain Damage, Chronic, Brain Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT04330859
Brain Damage, Chronic, Brain Diseases
Charlottesville, Virginia, United States
View Trial DetailsNCT03372590
Brain Damage, Chronic, Brain Diseases
Charlottesville, Virginia, United States
View Trial DetailsNCT00749008
Brain Damage, Chronic, Brain Diseases
Honolulu, Hawaii, United States
View Trial Details